Transcatheter Pulmonary Valve Market Analysis By Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, Tetralogy Of Fallot, Truncus Arteriosus), And Segment Forecasts, 2014 - 2025

Published: Mar, 2017 | Pages: 137 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The global transcatheter pulmonary valve market is expected to reach a value of USD 54.1 million by 2025, according to a new report by Grand View Research, Inc. The technological advancements pertaining to heart valve technologies, and increasing number of clinical trials pipeline by various public and private players are some of the crucial factors expected to boost the market over the forecast period.

In 2015, North America held the majority of market share of nearly 80.6% in the global market. Some of the major drivers are increasing prevalence of the various cardiovascular disorders, growing geriatric population with heart valve diseases such as pulmonary stenosis, pulmonary regurgitation, and others, and rising awareness regarding the benefits of transcatheter valves over surgical procedures. The growing number of patients suffering from long-term heart disorders, rising awareness about technologically advanced heart valve, and increasing healthcare expenditures and reimbursement policies for overall transcatheter valves are some of the key contributors to the growth of the market globally.

However, Asia Pacific is expected to show a growth in this market after 2019, as there will be several product launch in this region. The Asia Pacific region is expected to grow at a lucrative growth rate owing to the growth of many developing economies like Japan and China. These developing countries show a potential of growth due to various contributors such as the increasing aging population and growing prevalence of heart diseases. Moreover, the presence of a large pool of patients, developing healthcare infrastructure & services, increasing disposable income, and rising government funding are some of the factors that are expected to drive the market during the forecast period.

Further Key Findings From the Study Suggest:

In 2015, tetralogy of Fallot (ToF) was the largest application segment, owing to the growing prevalence of ToF and the presence of huge product portfolio

In 2015, balloon transcatheter valve segment held majority of the revenue share and is expected to be the fastest growing market during the forecast period

The presence of huge patient base and growing interest among the private and public players to launch product after the completion of clinical trial in 2017 is expected to drive the Asia Pacific market

Some of the key players are Boston Scientific Corporation, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences Corporation, JenaValve Technology, Inc., St. Jude Medical, SYMETIS, Colibri Heart Valve, LLC, VENUS MEDTECH, and XELTIS.

 Table of Content

Chapter 1 Research Methodology
                    1.1 Information Procurement
                        1.1.1 Purchased database:
                        1.1.2 GVR's internal database
                    1.2 Primary Research:
                        1.2.1 List of primary sources include:
Chapter 2 Executive Summary
                    2.1 Market Snapshot
Chapter 3 Transcatheter Pulmonary Valve Market Variables, Trends & Scope
                    3.1 Market Segmentation & Scope
                        3.1.1 Market driver analysis
                             3.1.1.1 Growing prevalence of cardiovascular disorder
                                  3.1.1.1.1 Rheumatic heart diseases (RHD)
                             3.1.1.2 Increasing incidences of congenital heart diseases (CHD)
                             3.1.1.3 Technological advancement in heart valves
                        3.1.2 Market restraint analysis
                             3.1.2.1 Lack of well-defined insurance coverage & reimbursement scenario
                    3.2 Penetration & Growth Prospect Mapping
                    3.3 Transcatheter Valve- SWOT Analysis, By Factor (political & legal, economic and technological)
                    3.4 Industry Analysis - Porter's
                    3.5 Heat Map Analysis
                    3.6 Transcatheter Pulmonary Valve Average Selling Price Estimates and Forecasts, by Country, 2013 - 2025 (USD)
                    3.7 Product Pipeline Analysis
                    3.8 Regulatory Scenario
                    3.9 Distribution Network Heart Valve Market and Sales Agencies Operating by Countries
                        3.9.1 Regional distribution centers for the transcatheter pulmonary heart valve
Chapter 4 Transcatheter Pulmonary Valve: Technology Estimates & Trend Analysis
                    4.1 Transcatheter Valve Market: Technology Movement Analysis
                    4.2 Balloon-Expanded Transcatheter Valve
                        4.2.1 Balloon-expanded transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                    4.3 Self-Expanded Transcatheter Valve
                        4.3.1 Self-expanded transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
Chapter 5 Transcatheter Pulmonary Valve: End-Use Estimates & Trend Analysis
                    5.1 Transcatheter Pulmonary Valve Market: End-Use Movement Analysis
                    5.2 Adult
                        5.2.1 Adult transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                    5.3 Pediatric
                        5.3.1 Pediatric transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
Chapter 6 Transcatheter Pulmonary Valve: Application Estimates & Trend Analysis
                    6.1 Transcatheter Pulmonary Valve Market: Application Movement Analysis
                    6.2 Cardiac Anomaly
                        6.2.1 Cardiac anomaly market estimates and forecasts, 2013 - 2025 (USD Million)
                    6.3 Pulmonary Atresia
                        6.3.1 Pulmonary atresia market estimates and forecasts, 2013 - 2025 (USD Million)
                    6.4 Pulmonary Stenosis
                        6.4.1 Pulmonary stenosis market estimates and forecasts, 2013 - 2025 (USD Million)
                    6.5 Pulmonary Regurgitation
                        6.5.1 Pulmonary regurgitation market estimates and forecasts, 2013 - 2025 (USD Million)
                    6.6 Tetralogy of Fallot
                        6.6.1 Tetralogy of Fallot market estimates and forecasts, 2013 - 2025 (USD Million)
                    6.7 Truncus Arteriosus
                        6.7.1 Truncus arteriosus market estimates and forecasts, 2013 - 2025 (USD Million)
                    6.8 Others
                        6.8.1 Other application market estimates and forecasts, 2013 - 2025 (USD Million)
Chapter 7 Transcatheter Pulmonary Valve: Raw Material Estimates & Trend Analysis
                    7.1 Transcatheter Pulmonary Valve Market: Raw Material Movement Analysis
                    7.2 Synthetic
                        7.2.1 Synthetic valve market estimates and forecasts, 2013 - 2025 (USD Million)
                    7.3 Tissue Engineered
                        7.3.1 Tissue engineered valve market estimates and forecasts, 2013 - 2025 (USD Million)
Chapter 8 Transcatheter Pulmonary Valve: Regional Estimates & Trend Analysis, by Technology, End-Use, Application, and Raw Material
                    8.1 Transcatheter Pulmonary Valve Market Share by Region, 2013 & 2025
                    8.2 North America
                        8.2.1 North America transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.2.2 U.S.
                             8.2.2.1 U.S. transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.2.3 Canada
                             8.2.3.1 Canada transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                    8.3 Europe
                        8.3.1 Europe transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.3.2 Germany
                             8.3.2.1 Germany transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.3.3 UK
                             8.3.3.1 UK transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.3.4 Russia
                             8.3.4.1 Russia transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.3.5 France
                             8.3.5.1 France transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.3.6 Italy
                             8.3.6.1 Italy transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.3.7 Spain
                             8.3.7.1 Spain transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                    8.4 Asia Pacific
                        8.4.1 Asia Pacific transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.4.2 Japan
                             8.4.2.1 Japan transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.4.3 China
                             8.4.3.1 China transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.4.4 Taiwan
                             8.4.4.1 Taiwan transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.4.5 Hong Kong
                             8.4.5.1 Hong Kong transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                    8.5 Latin America
                        8.5.1 Latin America transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.5.2 Brazil
                             8.5.2.1 Brazil transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.5.3 Mexico
                             8.5.3.1 Mexico transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                    8.6 MEA
                        8.6.1 MEA transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
                        8.6.2 South Africa
                             8.6.2.1 South Africa transcatheter pulmonary valve market estimates and forecasts, 2013 - 2025 (USD Million)
Chapter 9 Competitive Landscape
                    9.1 Company Profiles
                        9.1.1 Boston Scientific Corporation
                             9.1.1.1 Company overview
                             9.1.1.2 Financial performance
                             9.1.1.3 Strategic initiatives
                        9.1.2 Braile Biomedica
                             9.1.2.1 Company overview
                             9.1.2.2 Strategic initiatives
                        9.1.3 Direct Flow Medical, Inc.
                             9.1.3.1 Company overview
                             9.1.3.2 Financial performance
                             9.1.3.3 Strategic initiatives
                        9.1.4 Edward Lifesciences Corporation
                             9.1.4.1 Company overview
                             9.1.4.2 Financial performance
                             9.1.4.3 Product benchmarking
                             9.1.4.4 Strategic initiatives
                        9.1.5 JenaValve Technology, Inc.
                             9.1.5.1 Company overview
                             9.1.5.2 Financial performance
                             9.1.5.3 Strategic initiatives
                        9.1.6 Medtronic
                             9.1.6.1 Company overview
                             9.1.6.2 Financial performance
                             9.1.6.3 Product benchmarking
                             9.1.6.4 Strategic initiatives
                        9.1.7 St. Jude Medical
                             9.1.7.1 Company overview
                             9.1.7.2 Financial performance
                             9.1.7.3 Strategic initiatives
                        9.1.8 SYMETIS SA
                             9.1.8.1 Company overview
                             9.1.8.2 Strategic initiatives
                        9.1.9 Xeltis
                             9.1.9.1 Company overview
                             9.1.9.2 Financial performance
                             9.1.9.3 Product benchmarking
                             9.1.9.4 Strategic initiatives
                        9.1.10 Venus Medtech
                             9.1.10.1 Company overview
                             9.1.10.2 Financial performance
                             9.1.10.3 Product benchmarking
                             9.1.10.4 Strategic initiatives
                        9.1.11 LivaNova PLC.(Sorin Group)
                             9.1.11.1 Company overview
                             9.1.11.2 Financial performance
                             9.1.11.3 Strategic initiatives
                        9.1.12 Cryolife, Inc.
                             9.1.12.1 Company overview
                             9.1.12.2 Financial performance
                             9.1.12.3 Product benchmarking
                             9.1.12.4 Strategic initiatives
                        9.1.13 Colibri Heart Valve, LLC
                             9.1.13.1 Company overview
                             9.1.13.2 Financial performance
                             9.1.13.3 Product benchmarking
                             9.1.13.4 Strategic initiatives

List of Tables

TABLE 1 The incidence of cardiovascular diseases by country in 2015
TABLE 2 The number of deaths due to rheumatic heart diseases by region
TABLE 3 The number of deaths due to inflammatory heart disease by region
TABLE 4 The incidence of various form of congenital heart diseases (CHD), by disease type
TABLE 5 Country wise TPV average selling price estimates and forecast, 2013 - 2025 (USD)
TABLE 6 List of clinical trial pipeline with existing product, by company name, conditions, phase type, number of enrolment
TABLE 7 List of product pipelines
TABLE 8 Regulatory history of the existing product base
TABLE 9 Medtronic Asia Pacific Region
TABLE 10 Medtronic European Region
TABLE 11 Medtronic Latin American Region
TABLE 12 Medtronic North American Region
TABLE 13 Medtronic MEA Region
TABLE 14 Edwards Lifesciences Corporation Asia Pacific Region
TABLE 15 Edwards Lifesciences Corporation Europe, Middle East and Africa Region
TABLE 16 Edwards Lifesciences Corporation Latin American Region
TABLE 17 Edwards Lifesciences Corporation North American Region
TABLE 18 CryoLife Europe Region
TABLE 19 CryoLife Asia Pacific Region
TABLE 20 CryoLife North and South American Region
TABLE 21 North America transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 22 North America transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 23 North America transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 24 North America transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 25 U.S. transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 26 U.S. transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 27 U.S. transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 28 U.S. transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 29 Canada transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 30 Canada transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 31 Canada transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 32 Canada transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 33 Europe transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 34 Europe transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 35 Europe transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 36 Europe transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 37 Germany transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 38 Germany transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 39 Germany transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 40 Germany transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 41 UK transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 42 UK transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 43 UK transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 44 UK transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 45 Russia transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 46 Russia transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 47 Russia transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 48 Russia transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 49 France transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 50 France transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 51 France transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 52 France transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 53 Italy transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 54 Italy transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 55 Italy transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 56 Italy transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 57 Spain transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 58 Spain transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 59 Spain transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 60 Spain transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 61 Asia Pacific transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 62 Asia Pacific transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 63 Asia Pacific transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 64 Asia Pacific transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 65 Japan transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 66 Japan transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 67 Japan transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 68 Japan transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 69 China transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 70 China transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 71 China transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 72 China transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 73 Taiwan transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 74 Taiwan transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 75 Taiwan transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 76 Taiwan transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 77 Hong Kong transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 78 Hong Kong transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 79 Hong Kong transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 80 Hong Kong transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 81 Latin America transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 82 Latin America transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 83 Latin America transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 84 Latin America transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 85 Brazil transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 86 Brazil transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 87 Brazil transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 88 Brazil transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 89 Mexico transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 90 Mexico transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 91 Mexico transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 92 Mexico transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 93 MEA transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 94 MEA transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 95 MEA transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 96 MEA transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)
TABLE 97 South Africa transcatheter pulmonary valve market, by technology, 2013 - 2025 (USD Million)
TABLE 98 South Africa transcatheter pulmonary valve market, by end-use, 2013 - 2025 (USD Million)
TABLE 99 South Africa transcatheter pulmonary valve market, by application, 2013 - 2025 (USD Million)
TABLE 100 South Africa transcatheter pulmonary valve market, by raw material, 2013 - 2025 (USD Million)